FDA Clearance Tracker · P200045-S002
RelayPro Thoracic Stent-Graft System
Last checked: Nov 20, 2026Latest source record: Mar 7, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Mar 7, 2023
Approved
Time to decision
295 days
Received May 16, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P200045-S002
- Device name
- RelayPro Thoracic Stent-Graft System
- Applicant
- Bolton Medical, Inc.
- Applicant location
- Sunrise, FL
- Received
- May 16, 2022
- Decided
- Mar 7, 2023
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P200045
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval of the RelayPro Thoracic Stent Graft System for treatment of all lesions of the descending thoracic aorta. The RelayPro Thoracic Stent-Graft System is indicated for the endovascular repair of all lesions of the descending thoracic aorta in patients having appropriate anatomy, including:1) Iliac or femoral access vessel morphology that is compatible with vascular access techniques, devices, and/or accessories;2) Non-aneurysmal aortic neck diameter in the range of 20 to 42 mm (fusiform aneurysms and saccular aneurysms/penetrating atherosclerotic ulcers) or proximal and distal landing zones with diameters between 19 to 42 mm (traumatic aortic injuries);3) Non-aneurysmal proximal aortic neck lengths (fusiform aneurysms and saccular aneurysms/penetrating atherosclerotic ulcers) or landing zones (traumatic aortic injuries) of: a. 15 mm for the 22 to 28 mm device diameters (Bare Stent Configuration) b. 20 mm for the 30 to 38 mm device diameters (Bare Stent Configuration) c. 25 mm for the 40 to 46 mm device diameters (Bare Stent Configuration) d. 25 mm for the 22 to 38 mm device diameters (Non-Bare Stent Configuration) e. 30 mm for the 40 to 46 mm device diameters (Non-Bare Stent Configuration)4) Non-aneurysmal distal aortic neck lengths (fusiform aneurysms and saccular aneurysms/penetrating atherosclerotic ulcers) of: a. 25 mm for the 24 to 38 mm device diameters b. 30 mm for the 40 to 46 mm device diameters5) Non-aneurysmal distal landing zone of 20 mm for traumatic aortic injuries (22 to 46mm device diameters) and dissections (24 to 46mm device diameters)The RelayPro Thoracic Stent-Graft System (NBS configuration) is indicated for the endovascular distal extension of the Thoraflex Hybrid device.
Source documents
Other decisions for Bolton Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P200045 · Decided Aug 5, 2021 · 258 days after receipt
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
P190015 · Decided May 4, 2020 · 336 days after receipt
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.